Evidence-Based Medicine

Also known as: EBM

framework · medicine · structured-empirical

Sackett's integration of best research evidence, clinical expertise, and patient values.

Evidence-Based Medicine (EBM) is the framework articulated by David Sackett and colleagues at McMaster University in the early 1990s (substantial development from 1981 'How to Read Clinical Journals' series; foundational 1992 JAMA paper 'Evidence-Based Medicine: A New Approach to Teaching the Practice of Medicine' by the Evidence-Based Medicine Working Group; 1996 Sackett et al. BMJ 'Evidence Based Medicine: What It Is and What It Isn't'). Sackett's foundational definition: 'Evidence-based medicine is the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients. The practice of evidence-based medicine means integrating individual clinical expertise with the best available external clinical evidence from systematic research.' EBM's central commitments include: (1) hierarchy of evidence with randomized controlled trials (RCTs) and systematic reviews/meta-analyses at top, observational studies and case reports lower; (2) systematic literature search and critical appraisal of research evidence; (3) integration of best evidence with clinical expertise and patient values/preferences; (4) explicit reasoning from evidence to clinical decisions. The framework substantially shaped contemporary medicine through: substantial expansion of systematic reviews (Cochrane Collaboration founded 1993 with substantial subsequent development); clinical practice guidelines based on evidence synthesis; medical education emphasis on critical appraisal skills; healthcare quality and reimbursement based on evidence-based practices. EBM has faced substantial published critique — Trisha Greenhalgh, Jeremy Howick, and Neal Maskrey's 2014 BMJ paper 'Evidence Based Medicine: A Movement in Crisis?' substantially documented concerns including: industry capture (pharmaceutical companies sponsor most RCTs, with substantial selective publication and analysis biases); over-reliance on guidelines that don't fit individual patients (the 'evidence biased medicine' phenomenon); excessive volume of evidence overwhelming clinical capacity; reduction of expert clinical judgment to algorithmic guideline-following; substantial gap between evidence and implementation. EBM remains foundational to contemporary medicine but faces ongoing debate about implementation and limitations.

Originators

David Sackett (McMaster University foundational); Gordon Guyatt (substantial development, coined 'evidence-based medicine'); Brian Haynes; David Eddy (clinical decision analysis precursor); Archie Cochrane (Effectiveness and Efficiency 1972, intellectual antecedent); Evidence-Based Medicine Working Group (1992 JAMA paper) high

Year / Decade

1972 (Cochrane intellectual antecedent); 1981 (McMaster 'How to Read Clinical Journals'); 1992 (foundational JAMA paper); 1996 (Sackett et al. BMJ articulation); ongoing development high

Primary sources

Evidence-Based Medicine Working Group (1992). 'Evidence-Based Medicine: A New Approach to Teaching the Practice of Medicine', JAMA, Sackett, D.L., Rosenberg, W.M.C., Gray, J.A.M., Haynes, R.B. & Richardson, W.S. (1996). 'Evidence Based Medicine: What It Is and What It Isn't', BMJ, Sackett, D.L. et al. (1997, multiple editions). Evidence-Based Medicine: How to Practice and Teach EBM, Greenhalgh, T., Howick, J. & Maskrey, N. (2014). 'Evidence Based Medicine: A Movement in Crisis?', BMJ (substantial critique) high

Core components

Hierarchy of evidence (RCTs and systematic reviews at top)
Systematic literature search and critical appraisal
Integration of evidence with clinical expertise and patient values
Five-step process: ask, acquire, appraise, apply, audit/assess
Cochrane Collaboration (1993 founding) for systematic reviews
Clinical practice guidelines
Medical education emphasis on critical appraisal
Application across clinical practice, healthcare quality, reimbursement
Recent extensions: shared decision-making, patient values integration
Substantial published critique including Greenhalgh-Howick-Maskrey 2014

Primary use case

Foundational framework in contemporary medicine globally; basis for clinical practice guidelines, quality measures, healthcare reimbursement; reference framework in essentially every contemporary medical curriculum; foundation for Cochrane Collaboration and systematic-review industry; integration with broader healthcare quality and improvement; pedagogical foundation in medical education; influence on healthcare policy and pharmaceutical regulation; foundation for some commercial healthcare-consulting and clinical-decision-support practices.

Common criticisms

Substantial published critique: Greenhalgh-Howick-Maskrey 2014 BMJ 'Evidence Based Medicine: A Movement in Crisis?' documented multiple concerns: industry capture (pharmaceutical industry sponsors substantial proportion of RCTs, with substantial selective publication, analysis, and reporting biases that skew evidence base)
over-reliance on guidelines that don't fit individual patients (evidence-biased medicine — guideline rigidity at expense of clinical judgment)
excessive evidence volume overwhelming clinical capacity (PubMed adds papers faster than physicians can read)
reduction of expert clinical judgment to algorithmic guideline-following
substantial gap between evidence and clinical implementation
the RCT primacy in evidence hierarchy underweights observational evidence that better fits some clinical questions (rare diseases, ethical limits on randomization, real-world effectiveness vs efficacy)
replication crisis in biomedical research substantially complicates 'best evidence' claims
cross-cultural and cross-context generalization from RCT populations to actual clinical populations is genuinely difficult
commercial pharmaceutical industry's substantial financial stake in EBM framings shapes evidence base in ways the framework doesn't always acknowledge
tendency for EBM to elevate procedural correctness over substantive clinical judgment
integration with patient values is often weak in practice despite formal commitment
cross-condition generalization is incomplete — EBM works better for some clinical questions (acute treatment efficacy) than for others (complex chronic care, multimorbidity, preventive care)
recent shared-decision-making movement substantially extends EBM but raises questions about integration.

Lineage

Siblings: Clinical Reasoning